Vertex Pharmaceuticals

November is here, and with it comes #DiabetesAwarenessMonth. We’re taking a moment to reflect on the annual Breakthrough T1D (formerly JDRF) OneWalk in September, where we had the honor of joining the type 1 diabetes (T1D) community for a meaningful day of connection, advocacy and raising awareness for T1D. Huge thanks to Breakthrough T1D and Breakthrough T1D Greater New England for organizing a great event!

Each day, we’re inspired by the patient communities we hope to serve. This month is #Alpha1AwarenessMonth, and we’re proud to light up our #Boston building purple to show our support for those living with alpha-1 antitrypsin deficiency (AATD).

What’s your blood type? In recognition of Black History Month UK, our VIBE (Vertex Includes Boundless Ethnicities) employee resource network partnered with the UK’s National Health Service and Paddington Central to host an awareness event giving people the opportunity to discover their blood type and register to be a blood donor. Giving blood, especially for those with rare blood types, is one of the ways we can support those living with serious diseases such as sickle cell disease and transfusion-dependent beta thalassemia.

We’re proud to announce that we’ve been named on the 2024 TIME Best Inventions list, which recognizes a wide variety of new products, software or services that are making a difference in the world.

Jenna (Stento) Harrington, who leads our U.S. pain business unit, is making an impact at Vertex, in the Boston community and beyond. And we’re thrilled that she’s been recognized as one of the Boston Business Journal 40 under 40 honorees for 2024. Jenna has the unique ability to lead, motivate and drive success — all while caring deeply about her team and the patients we serve. Congrats Jenna! #BBJ4040

This Diabetes Awareness Month we recognize type 1 diabetes (T1D) and the daily impact of this disease. We brought five people living with T1D together to share their experiences. The group talks about the impacts of this disease—at home, at work, and at the doctor’s office—and why effective management starts with the patient-provider relationship: https://lnkd.in/eWVh3W_c

Meet Varsha Bhargava, a molecular and cell biology researcher here at Vertex. For her, Uncompromising Commitment to Patients means she gets to work toward a bigger purpose, but she knows she’s not alone. Visit https://lnkd.in/eetQgDsM to learn more about the values that drive us and explore open roles.

Last week our teams attended the American Society of Nephrology Annual Meeting where we engaged in meaningful discussions with other leaders committed to scientific innovation for diseases such as APOL-1 mediated kidney disease (AMKD), autosomal dominant polycystic kidney disease (ADPKD), and IgA nephropathy (IgAN). Thank you to American Society of Nephrology for hosting such a collaborative and informative event!

Patients are the “why” behind our work at Vertex. This November, we’re proud to support the many patients, families and caregivers who are affected by alpha-1 antitrypsin deficiency (AATD) to help raise awareness and amplify the voices of the alpha-1 community. #Alpha1AwarenessMonth

We are excited to share new data from multiple investigational kidney disease programs at the 2024 American Society of Nephrology Kidney Week Congress. Learn more: https://lnkd.in/eu7BdwEe #KidneyWk